Printer Friendly

-Meda buys three OTC products in USA for SEK235m.

NORDIC BUSINESS REPORT-December 14, 2010--Meda buys three OTC products in USA for SEK235m(C)2010 M2 COMMUNICATIONS

14 December 2010 - Swedish pharma company Meda AB (STO: MEDA A) said today it has acquired three over-the-counter consumer products from US sector player GlaxoSmithKline LLC for SEK235m.

The products have combined annual sales corresponding to SEK100m, with strong profit margins. Meda did not disclose any further details about the drugs.

GlaxoSmithKline LLC is part of UK-based healthcare group GlaxoSmithKline plc (LON: GSK), or GSK. Meda and GSK are discussing potential additional OTC deals in the US market.

(EUR1 = SEK9.1)

((Comments on this story may be sent to

COPYRIGHT 2010 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Date:Dec 14, 2010
Previous Article:-Ikea picks Peab to build ten stores in Nordic region.
Next Article:-NCC sells port project in Swedish Gothenburg for SEK188m.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters